Carnitine: A nutritional, biosynthetic, and functional perspective

Molecular Aspects of Medicine

Volumn 25, Issue 5-6, 2004, Pages 455-473

  Steiber, Alison ^a   Kerner, Janos ^a   Hoppel, Charles L ^b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Biosynthesis; Carnitine; Carnitine palmitoyltransferase; Dietary; Malonyl CoA

Indexed keywords

ANION CHANNEL; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; MALONYL COENZYME A;

AMINO ACID SYNTHESIS; AMINO ACID TRANSPORT; BIOSYNTHESIS; CATALYSIS; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME REGULATION; FOOD ANALYSIS; FOOD COMPOSITION; HUMAN; INTRACELLULAR TRANSPORT; MITOCHONDRION; NONHUMAN; NUTRITION; NUTRITIONAL PARAMETERS; NUTRITIONAL VALUE; OXIDATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOENZYMATIC ASSAY; REGULATORY MECHANISM; REVIEW;

EID: 4444315751     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2004.06.006     Document Type: Article

References (99)

1. Abu-Elheiga L., Matzuk M.M., Abo_Hashema K., Wakil S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 291:2001;2613-2616
2. Alkonyi I., Cseko J., Sandor A. Role of the liver in carnitine metabolism: the mechanism of development of carnitine-deficient status in guinea pigs. J. Clin. Chem. Clin. Biochem. 28(5):1990;319-321
3. Aseo I., Tindimwebwa G., Agu E., Iputo J.E. Serum free carnitine levels in children with kwashiorkor. East Afr. Med. J. 76:1999;562-565
4. Bartlett K., Eaton S. Mitochondrial β-oxidation. Eur. J. Biochem. 271:2004;462-469
5. Benz R., Wojtczak L., Bosch W., Brdiczka D. Inhibition of adenine nucleotide transport through the mitochondrial porin by a synthetic polyanion. FEBS Lett. 231:1988;75-80
6. Bieber L.L. Carnitine. Ann. Rev. Biochem. 57:1988;61-283
7. Bieber L.L., Emaus R., Valkner K., Farrell S. Possible functions of short-chain and medium-chain carnitine acyltransferases. Fed. Proc. 41:1982;2858-2862
8. Bohles H., Ullrich K., Endres W., Behbehani A.W., Wendel U. Inadequate iron availability as a possible cause of low serum carnitine concentrations in patients with phenylketonuria. Eur. J. Pediatr. 150:1991;425-428
9. Brady L.J., Silverstein L.J., Hoppel C.L., Brady P.S. Hepatic mitochondrial inner membrane properties and carnitine palmitoyltransferase A and B. Biochem. J. 232:1985;445-450
10. Brass E.P. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin. Ther. 17:1995;176-185
11. Brass E.P., Mayer M.D., Mulford D.J., Stickler T.K., Hoppel C.L. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Clin. Pharmacol. Ther. 73:2003;338-347
12. Bremer J. The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. Biochim. Biophys. Acta. 665:1981;628-631
13. Bremer J. Carnitine-metabolism and function. Physiol. Rev. 63:1983;1420-1480
14. Cederblad G. Effect of diet on plasma carnitine levels and urinary carnitine excretion in humans. Am. J. Clin. Nutr. 45:1987;725-729
15. Cederblad G., Lindstedt S. A method for the determination of carnitine in the picomole range. Clin. Chim. Acta. 37:1972;235-243
16. Chalmers R.A., Roe C.R., Stacey T.E., Hoppel C.L. Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine. Pediatr. Res. 18:1984;1325-1328
17. Chen W., Huang Y.C., Shultz T.D., Mitchell M.E. Urinary, plasma, and erythrocyte carnitine concentrations during transition to a lactoovovegetarian diet with vitamin B-6 depletion and repletion in young adult women. Am. J. Clin. Nutr. 67:1998;221-230
18. Cho Y.O., Leklem J.E. In vivo evidence for a vitamin B-6 requirement in carnitine synthesis. J. Nutr. 120:1990;258-265
19. Colombini M., Yeung C.L., Tung J., Konig T. The mitochondrial outer membrane channel, VDAC, is regulated by a synthetic polyanion. Biochim. Biophys. Acta. 905:1987;279-286
20. Davis A.T., Ingalls S.T., Hoppel C.L. Determination of free trimethyllysine in plasma and tissue speciemans by high-performance liquid chromotography. J. Chromatogr. 306:1984;79-87
21. de Vries Y., Arvidson D.N., Waterham H.R., Cregg J.M., Woldegiorgis G. Functional characterization of mitochondrial carnitine palmitoyltransferase I and II expressed in the yeast Pichia pastoris. Biochemistry. 36:1997;5285-5292
22. Dyck J.R.B., Cheng J.-F., Stanley W.C., Barr R., Chandler M.P., Brown S., Wallace D., Arrhenius T., Harmon C., Yand G., Nadzan A.M., Lopaschuk G.G. Malonyl coenzyme A decarboxylase inhibition protecs the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ. Res. 94:2004;e78-e84
23. Eaton S., Purfarzam M., Bartlett K. The effect of respiratory chain impairment of beta-oxidation in rat heart mitochondria. Biochem. J. 319:1996;633-640
24. Eaton S., Bartlett K., Pourfarzam M. Mammalian mitochondrial beta-oxidation. Biochem. J. 320:1996;345-357
25. Enomoto A., Wempe M.F., Tsuchida H., Shin H.J., Cha S.H., Anzai N., Goto A., Sakamoto A., Niwa T., Kanai Y., Anders M.W., Endou H. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J. Biol. Chem. 277:2002;36262-36271
26. Erfle J.D., Fisher L.J., Sauer F. Caarnitine and acetylcarnitine in the milk of normal and ketotic cows. J. Dairy Sci. 53:1970;486-489
27. Ferreira I.M. Quantification of non-protein nitrogen components of infant formulae and follow-up milks: comparison with cows' and human milk. Br. J. Nutr. 90:2003;127-133
28. Ferreira I.M., Macedo M.N., Ferreira M.A. Enzymic flow injection determination of free L-carnitine in infant formulae. Analyst. 122:1997;1539-1541
29. Fraser F., Zammit V.A. Submitochondrial and subcellular distributions of the carnitine-acylcarnitine carrier. FEBS Lett. 445:1999;41-44
30. Fraser F., Corstorphine C.G., Zammit V.A. Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane. Biochem. J. 323:1997;711-718
31. Guzman M., Geelen M.J.H. Activity of carnitine palmitoyltransferase in mitochondrial outer membranes and peroxisomes in digitonin-permeabilized hepatocytes. Selective modulation of mitochondrial enzyme activity by okadaic acid. Biochem. J. 287:1992;487-492
32. Guzman M., Kolodziej M.P., Caldwell A., Corstorphine C.G., Zammit V.A. Evidence against direct involvement of phosphorylation in the activation of carnitine palmitoyltransferase by okadaic acid in rat hepatocytes. Biochem. J. 300:1994;693-699
33. Harper P., Elwin C.E., Cederblad G. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. Eur. J. Clin. Pharmacol. 35:1988;555-562
34. Harwood H.J., Petras S.F., Shelly L.D., Zaccaro L.M., Perry D.A., Makowski M.R., Hargrove D.M., Martin K.A., Tracey W.R., Chapman J.G., Magee W.P., Dalvie D.K., Soliman V.F., Martin W.H., Mularski C.J., Eisenbeis S.A. Isoenzyme-nonselective N-substituted bipireridylcarboxamidde acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and experimental animals. J. Biol. Chem. 278:2003;37099-37111
35. Holme E., Greter J., Jacobsen C.E., Lindstedt S., Nordin I., Kristiansson B., Jodal U. Carnitine deficiency induced by pivampicillim and pivmecillinam therapy. Lancet. 2:1989;469-473
36. Hoppel C.L. Carnitine palmitoyltransferase and transport of fatty acids. Martonosi A. The Enzymes of Biological Membranes. vol. 2:1976;119-143 Plenum, New York
37. Hoppel C.L. Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis. Fed. Proc. 41:1982;2853-2857
38. Hoppel C.L., Genuth S.M. Carnitine metabolism in normal-weight and obese human subjects during fasting. Am. J. Physiol. 238:1980;E409-E415
39. Hoppel C., Kerner J., Distler A., Minkler P. Phosphorylation of rat liver carnitine palmitoyltransferase-I. FASEB J. 18:2004;A862
40. Hoppel C., Kerner J., Turkaly P., Minkler P., Tandler B. Isolation of hepatic mitochondrial contact sites: previously unrecognized inner membrane components. Anal. Biochem. 302:2002;60-69
41. Hulse J.D., Ellis S.R., Henderson L.M. Carnitine biosynthesis, β-Hydroxylation of trimethyllysine by an α-ketoglutarate-dependent mitochondrial dioxygenase. J. Biol. Chem. 253:1978;1654-1659
42. Jacobs B.S., Wanders R.J.A. Fatty acid β-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propinyl-CoA from peroxisomes to mitochondria. Biochem. Biophys. Res. Commun. 213:1995;1035-1041
43. Johnston C.S., Solomon R.E., Corte C. Vitamin C depletion is associated with alterations in blood histamine and plasma free carnitine in adults. J. Am. Coll. Nutr. 15:1996;586-591
44. Kerner, J., Distler, A.M., Minkler, P.E., Parland, W., Peterman, S.M., 2004. Phosphorylation of rat liver mitochondrial carnitine palmitoyltransferase- I (CPT-I): Effect on the enzyme's kinetic properties. J. Biol. Chem. 2004 July 9 [Epub ahead of print]
45. Kerner J., Hoppel C. Genetic disorders of carnitine metabolism and their nutritional management. Ann. Rev. Nutr. 18:1998;179-206
46. Kerner J., Hoppel C. Fatty acid import into mitochondria. Biochim. Biophys. Acta. 1486:2000;1-17
47. Khan-Siddiqui L., Bamji M.S. Plasma carnitine levels in adult males in India: effects of high cereal, low fat diet, fat supplementation, and nutrition status. Am. J. Clin.Nutr. 33:1980;1259-1263
48. Kolodziej M.P., Zammit V.A. Mature carnitine palmitoyltransferase I retains the N-terminus of the nascentprotein in rat liver. FEBS Lett. 327:1993;294-296
49. Konig T., Kocsis B., Meszaros L., Nahm K., Zoltan S., Horvath I. Interaction of a synthetic polyanion with rat liver mitochondria. Biochim. Biophys. Acta. 462:1977;380-389
50. Krajcovicova-Kudlackova M., Simoncic R., Bederova A., Babinska K., Beder I. Correlation of carnitine levels to methionine and lysine intake. Physiol. Res. 49:2000;399-402
51. Kunau W.-H., Dommes V., Schulz H. Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog. Lipid Res. 34:1995;267-342
52. Lennon D.L., Shrago E.R., Madden M., Nagle F.J., Hanson P. Dietary carnitine intake related to skeletal muscle and plasma carnitine concentrations in adult men and women. Am. J. Clin.Nutr. 43:1986;234-238
53. Lombard K.A., Olson A.L., Nelson S.E., Rebouche C.J. Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am. J. Clin. Nutr. 50:1989;301-306
54. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244:1997;1-14
55. McGarry J.D., Leatherman G.F., Foster D.W. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J. Biol. Chem. 253:1978;4128-4136
56. Melegh B., Kerner J., Bieber L.L. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem. Pharmacol. 36:1987;3405-3409
57. Mikhail M.M., Mansour M.M. The relationship between serum carnitine levels and the nutritional status of patients with schistosomiasis. Clin. Chim. Acta. 71:1976;207-214
58. Minkler, P.E., Kerner, J., North, K.N., Hoppel, C.L., 2004. Quantitation of long-chain acylcarnitines by HPLC/fluorescence detection: application to plasma and tissue specimens from patients with carnitine palmitoyltransferase-II deficiency. Clin. Chim. Acta, in press
59. Murthy M.S.R., Pande S.V. Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on opposite sides of the mitochondrial membrane. Proc. Natl. Acad. Sci. USA. 84:1987;378-382
60. Mynatt R.L., Greenhaw J.J., Cook G.A. Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids. Biochem. J. 299:1994;761-767
61. Nada M.A., Rhead W.J., Sprecher H., Schulz H., Roe C.R. Evidence for intermediate channeling in mitochondrial beta-oxidation. J. Biol. Chem. 270:1995;530-535
62. --coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J. Physiol. 532:2001;297-304
63. Panter R.A., Mudd J.B. Carnitine levels in some higher plants. FEBS Lett. 5:1969;169-170
64. Pegorier J.-P., Garcia-Garcia M., Prip-Buus C., Duee P.-H., Kohl C., Girard J. Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment. Biochem. J. 264:1989;93-100
65. Poirier M., Vincent G., Reszko A.E., Bouchard B., Kelleher J.K., Brunengraber H., Des Rosiers C. Probing the link between citrate and malonyl-CoA in perfused rat hearts. Am. J. Physiol. 283:2002;H1379-H1386
66. Price N.T., van der Leij F.R., Jackson V.N., Corstophine C.G., Thomson R., Sorensen A., Zammit V.A. A novel barin-expressed protein related to carnitine palmitoyltransferase I. Genomics. 80:2002;433-442
67. Prip-Buus C., Cohen I., Kohl C., Esser V., McGarry J.D., Girard J. Topological and functional analysis of the rat liver carnitine palmitoyltransferase I expressed in Saccharomyces cerevisiae. FEBS Lett. 429:1998;173-178
68. Ramsay R.R., Gandour R.D., van der Leij F.R. Molecular enzymology of carnitine transfer and transport. Biochim. Biophys. Acta. 1546:2001;21-43
69. Rebouche C.J. Synthesis of carnitine precursors and related compounds. Methods Enzymol. 123:1986;290-297
70. Rebouche C.J., Bosch E.P., Chenard C.A., Schabold K.J., Nelson S.E. Utilization of dietary precursors for carnitine synthesis in human adults. J. Nutr. 119:1989;1907-1913
71. Rebouche C.J., Chenard C.A. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites 1. J. Nutr. 121:1991;539-546
72. Reszko A.E., Kasumov T., David F., Jobbins K.A., Thomas K.R., Hoppel C.L., Brunengraber H., Rosiers C. Peroxisomal fatty acid oxidation is a substantial source of the acetyl moiety of malonyl-CoA in rat heart. J. Biol. Chem. 279:2004;19574-19579
73. Robinson N., Zammit V.A. Sensitivity of carnitine acyltransferase I to malonly-CoA inhibition in isolated rat liver mitochondria is quantitatively related to hepatic malonyl-CoA concentration in vivo. Biochem. J. 206:1982;177-179
74. Roe C.R., Hoppel C.L., Stacey T.E., Chalmers R.A., Tracey B., Millington D.S. Metabolic response to carnitine in methylmalonic aciduria: an effective strategy for elimination of propionyl groups. Arch. Dis. Child. 58:1983;916-920
75. Roe C.R., Millington D.S., Maltby D.A., Kahler S.G., Bohan T.P. L-carnitine therapy in isovaleric acidemia. J. Clin. Invest. 74:1984;2290-2295
76. Rudman D., Sewell C.W., Ansley J.D. Deficiency of carnitine in cachectic cirrhotic patients. J. Clin. Invest. 60:1977;716-723
77. Sachan D.S., Broquist H.P. Synthesis of carnitine from epsilon-N-trimethyllysine in post mitochondrial fractions of Neurospora crassa. Biochem. Biophys. Res. Commun. 96:1980;870-875
78. Sachan D.S., Hoppel C.L. Carnitine biosynthesis. Hydroxylation of N6-trimethyl-lysine to 3-hydroxy-N6-trimethyl-lysine. Biochem. J. 188:1980;529-534
79. Saggerson E.D., Carpenter C.A. Effects of fasting, adrenalectomy and streptozotocin-diabetes on sensitivity of hepatic carnitine acyltransferase to malonyl CoA. FEBS Lett. 129:1981;225-228
80. Sahajwalla C.G., Helton E.D., Purich E.D., Hoppel C.L., Cabana B.E. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J. Pharm.Sci. 84:1995;627-633
81. Schaefer J., Pourfarzam M., Bartlett K., Jackson S., Turnbull D.M. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation. Pediatr. Res. 37:1995;354-360
82. Shi J., Zhu H., Arvidson D.N., Cregg J.M., Woldegiorgis G. Deletion of the conserved first 18 N-terminal amino acid residues in rat liver carnitine palmitoyltransferase I abolishes malonyl-CoA sensitivity. Biochemistry. 37:1998;11033-11038
83. Shi J., Zhu H., Arvidson D.N., Woldegiorgis G. A single amino acid change (substitution of glutamate 3 with alanine) in the N-terminal region of rat liver carnitine palmitolytransferase I abolishes malonyl-CoA inhibition and high affinity binding. J. Biol. Chem. 274:1999;9421-9426
84. Stakkestad J.A., Bremer J. The outer carnitine palmitoyltransferase and regulation of fatty acid metabolism in rat liver in different thyroid states. Biochim. Biophys. Acta. 750:1983;244-252
85. Swanson S.T., Foster D.W., McGarry J.D., Brown N.F. Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insight from expression of chimaeric proteins and mutation of conserved histidine residues. Biochem. J. 335:1998;513-519
86. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., Shimane M., Tsuji A. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J. Biol. Chem. 275:2000;40064-40072
87. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273:1998;20378-20382
88. Thoma W.J., Henderson L.M. Effect of vitamin C deficiency on hydration of trimethylaminobutyrate to carnitine in the guinea pig. Biochim. Biophys. Acta. 797(1):1984;136-139
89. Turkaly P., Kerner J., Hoppel C. A 22 kDa polyanion inhibits carnitine-dependent fatty acid oxidation in rat liver mitochondria. FEBS Lett. 460:1999;241-245
90. Van der Leij F.R., Huijkman N.C.A., Boomsma C., Kuipers J.R.G., Bartelds B. Genomics of the human carnitine acyltarsnferase genes. Mol. Genetics Metab. 71:2000;139-153
91. Velasco G., Geelen M.J.H., Gomez del Pulgar T., Guzman M. Possible involvement of cytoskeletal components in the control of hepatic carnitine palmitoyltransferase I activity. Adv. Exp. Med. Biol. 466:1999;43-52
92. Verhoeven N.M., Roe D.S., Kok R.M., Wanders R.J.A., Jacobs C., Roe C.R. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts. J. Lipid Res. 39:1998;66-74
93. Vickers S., Duncan C.A.H., White S.D., Ramjit H.G., Smith J.L., Walker R.W., Flynn H., Arinson B.H. Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica. 15:1985;453-458
94. Watmough N.J., Bhuiyan A.K.M.J., Bartlett K., Sherratt H.S.A., Turnbull D.M. Skeletal muscle mitochondrial beta-oxidation. A study of the products of oxidation of [U-14C]hexadecanoate by h.p.l.c. using continuous on-line radiochemical detection. Biochem. J. 253:1988;541-547
95. Wu X., George R.L., Huang W., Wang H., Conaway S.J., Leibach F.H., Ganapathy V. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochem. Biophys. Acta. 1466:2000;315-327
96. Yu G.-S., Lu Y.-C., Gulick T. Expression of novel isoforms of carnitine palmitoyltransferase I (CPT-I) generated by alternative splicing of the CPT-Iβ gene. Biochem. J. 334:1998;225-231
97. Yu G.-S., Lu Y.-C., Gulick T. Rat carnitine palmitoyltransferase Iβ mRNA splicing isoforms. Biochim. Biophys. Acta. 1393:1998;166-172
98. Zammit V.A., Corstorphine C., Kolodziej M., Fraser F. Lipid molecular order in liver mitochondrial outer membranes, and sensitivity of carnitine palmitoyltransferase I to malonyl-CoA. Lipids. 33:1998;371-376
99. Zhu H., Shi J., deVries Y., Arvidson D.N., Cregg J.M., Woldegiorgis G. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I. Arch. Biochem. Biophys. 347:1997;53-61